Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin vs Tavanic in Community-Acquired Pneumonia
NCT03551210Phase 3Completed
- Sponsor
- R-Pharm
- Start
- May 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of nemonoxacin in community acquired pneumonia (CAP), sponsored by R-Pharm. Started May 2016; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT03551210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03551210.